Ultrasound could stand in for MRI in evaluating muscle atrophy in diabetic patients, with the advantage of being a bedside tool, according to Danish researchers.
Ultrasound could stand in for MRI in evaluating muscle atrophy in diabetic patients, with the advantage of being a bedside tool, according to Danish researchers.
Dr. Kaare Severinsen in neurology and colleagues in the neuroradiology department of Aarhus University Hospital in Denmark performed ultrasound exams on two muscles in the feet of 26 diabetic patients and 26 matched controls. They also measured the volume of all foot muscles using volumetric functional MRI and established their clinical condition by testing nerve conduction and sensory perception thresholds. They published their study in Diabetes Care online ahead of print on Aug. 23, 2007.
With ultrasound, the researchers found extensor digitorum brevis muscles had a mean width of 6.4 ± 2.1 mm in diabetic patients and a mean cross-sectional area of 116 ± 65 mm². This showed significant atrophy versus the mean width of 9 ± 1 mm and mean cross-sectional area of 214 ± 38 mm² in controls.
The muscles of the first interstitium showed similar results, with a mean width of 29.6 ± 8.3 mm in diabetic patients and 40.2 ± 3.6 mm in controls.
The volume of the muscles as measured by MRI had a high correlation to the ultrasound measurements. Ultrasound showed both the extensor digitorum brevis muscle and the muscles of the first interstitium were thinner in neuropathic diabetic patients than in those without neuropathy.
The researchers concluded that ultrasound can show atrophy in muscles in the feet. It closely relates to MRI measurements and clinical indications of neuropathy in diabetic patients and could be useful as a beside test.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.